OcuSense  
Home | Contact Us | Non-U.S. Site
 
Home 
About Us 
Products 
Technology 
 
Corporate Background


OcuSense, an in-vitro diagnostics company headquartered in San Diego, California, is commercializing a proprietary tear testing platform, TearLab™, capable of rapidly and precisely measuring highly sensitive and specific biomarkers related to ocular physiology.

OcuSense plans to launch its first TearLab product for measuring tear film osmolarity in 2008. The Company is building a pipeline of other tests that can measure a range of clinically relevant protein biomarkers found in tears.




TearLab is an experimental device limited to investigational use in the US.  Not available for sale.
This page and its contents are for the U.S. market only. Click here for the EU market.